# Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients

> **NCT05226793** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 400 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05226793
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-17
- **Primary completion:** 2025-07-22
- **Final completion:** 2025-07-22
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05226793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05226793, "Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05226793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*